mRNA-1403

Moderna doses first subject in Phase III trial of mRNA norovirus vaccine in US
Clinical Trials Arena
Tue, 10/1/24 - 10:43 am
Moderna Therapeutics
mRNA-1403
vaccines
clinical trials
novovirus